2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000

1984 1985 1986 1987 1988 1989 1990

Scientific Publications 1999 [View all on PubMed]

  1. Barragan A, Spillmann D, Kremsner PG, Wahlgren M, Carlson J. Plasmodium falciparum: Molecular background to strain-specific rosette disruption by glycosamoinoglycans and sulfated glycoconjugates. Exp Parasitol. 1999 Feb;91(2):133-43 [Abstract]
  2. Conway DJ, Roper C, Oduola AM, Arnot DE, Kremsner PG, Grobusch MP, Curtis CF, Greenwood BM. High recombination rate in natural populations of Plasmodium falciparum. Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4506-11. [Abstract] [Free Full Article]
  3. Greve B, Lehman LG, Lell B, Luckner D, Schmidt-Ott R, Kremsner PG. High oxygen radical production is associated with fast parasite clearance in children with Plasmodium falciparum malaria. J nfect Dis. 1999 Jun;179(6):1584-6 [Abstract]
  4. Kremsner PG, Looareesuwan S, Chulay JD. Atovaquone and proguanil hydrochloride for treatment of malaria. J Travel Med . 1999 S18-S20. Kun JFJ, Klabunde J, Lell B, Luckner D, Alpers M, May J, Meyer C, Kremsner PG. Association of the ICAM-1 Kilifi mutation with protection against severe malaria in Lambaréné, Gabon. Am J Trop Med Hyg. 1999 Nov;61(5):776-9 [Abstract]
  5. Kun JFJ, Lehman LG, Lell B, Schmidt-Ott R, Kremsner PG. Low-dose treatment with sulfadoxine-pyrimethamine combinations selects for drug-resistant Plasmodium falciparum strains. Antimicrob Agents Chemother. 1999 Sep;43(9):2205-8 [Abstract] [Free Full Article]
  6. Lell B, May J, Schmidt-Ott RJ, Lehman LG, Luckner D, Greve B, Matousek P, Schmid D, Herbich K, Mockenhaupt FP, Meyer CG, Bienzle U, Kremsner PG. The role of red blood cell polymorphisms in resistance and susceptibility to malaria. Clin Infect Dis. 1999 Apr;28(4):794-9 [Abstract]
  7. Looareesuwan S, Chulay JD, Canfield CJ, Hutchinson DBA for the Malarone Clinical Trials Study Group. Malarone(TM) (atovaquone and proguanil hydrochloride): A review of its clinical development for treatment of malaria. Am J Trop Med Hyg. 1999 Apr;60(4):533-41 [Abstract]
  8. Luty AFJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, Greve B, Matousek P, Herbich K, Schmid D, Migot-Nabias F, Deloron P, Nussenzweig RS, Kremsner PG. Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J Infect Dis. 1999 Apr;179(4):980-8 [Abstract]
  9. May J, Meyer CG, Kun JFJ, Lell B, Luckner D, Dippmann AK, Bienzle U, Kremsner PG: HLA class II factors associated with Plasmodium falciparum merozoite surface antigen allele families. J Infect Dis. 1999 Apr;179(4):1042-5 [Abstract]
  10. Perkins DJ, Kremsner PG, Schmid D, Misukonis MA, Kelly MA, Weinberg JB. Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy Gabonese children with prior mild or severe malaria. Infect Immun. 1999 Sep;67(9):4977-81 [Abstract] [Free Full Article]
  11. Shanks GD, Kremsner PG, Sukwa TY, Van Der Berg JD, Shapiro TA, Scott TR, Chulay JD for the Malarone Clinical Trial Group. Atovaquone and proguanil hydrochloride for prophylaxis of malaria. J Travel Med. 1999 S21-S27 . Winkler S, Willheim M, Baier K, Aichelburg A, Kremsner PG, Graninger W. Increased frequency of Th2-type cytokine-producing T cells in microfilaremic loiasis. Am J Trop Med Hyg. 1999 Apr;60(4):680-6 [Abstract]
  12. Winkler S, Willheim M, Baier K, Graninger W, Kremsner PG. Frequency of cytokine-producing CD4- CD8- peripheral blood mononuclear cells in patients with Plasmodium falciparum malaria. Eur Cytokine Netw. 1999 Jun;10(2):155-60 [Abstract]
  13. Winkler S, Willheim M, Baier K, Schmid D, Aichelburg A, Graninger W, Kremsner PG. Frequency of cytokine-producing T cells in patients of different age groups with Plasmodium falciparum malaria. J Infect Dis. 1999 Jan;179(1):209-16 [Abstract]